Creating Confident Financial Positions

Raising capital and selling/buying securities can be a risky endeavor from a legal standpoint. At Doida Crow Legal, we have extensive experience in the multifaceted and highly regulated area of securities law, representing both private company issuers and investors. We help public and private company issuers comply with federal and state blue sky securities laws by assisting with due diligence preparation, corporate clean up matters, disclosure to investors (including private placement memos and disclosure statements), regulatory compliance, and closing the capital raise.

Likewise, we assist investors with review of due diligence and advise them of both business and legal proficiencies and deficiencies and significant risk factors in the issuing company.

Our team has led and/or provided significant representation in the following transactions:

  • Represented Issuing manufacturing company in a Reg A+ offering of up to $50 million in equity.
  • Represented the issuing biotechnology company in the private placement of $7.5 million convertible promissory notes and warrants to venture capital fund investors and other accredited investors and drafted the private placement memo.
  • Represented the issuing technology company in the sale of $1.5 million of Series A preferred stock to venture capital fund investors.
  • Represented the issuing company with the sale of $1.5 million in convertible notes to accredited investors with general solicitations (506(c)).
  • Represented the issuing real estate development company in the sale of $7.5 million of Class B LLC Units.
  • Represented the issuing technology company in the sale of $900,000 to accredited investors.
  • Represented the issuing residential real estate investment company in the private placement of $3 million of membership units to accredited investors and drafted the private placement memo.
  • Represented venture capital fund investors purchasing $2 million of Series C preferred stock of a SaaS company.
  • Represented the issuing biotechnology company in the private placement of $8 million in membership units to accredited investors and drafted the private placement memo.
  • Represented the issuing solar technology company in the private placement of $3 million of common stock to accredited investors and drafted the private placement memo.
© 2024 Doida Crow Legal | Privacy Policy | Disclaimer | Sitemap
Top